{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:25:36Z","timestamp":1763555136253,"version":"3.45.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.conctc.2018.08.008","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T02:59:05Z","timestamp":1534820345000},"page":"32-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A feasibility study prior to an international multicentre paediatric study to assess pharmacokinetic\/pharmacodynamic sampling and sample preparation procedures, logistics and bioanalysis"],"prefix":"10.1016","volume":"12","author":[{"given":"Agnes Maria","family":"Ciplea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Laeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjoern Bengt","family":"Burckhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.conctc.2018.08.008_bib1","first-page":"CC01","article-title":"Delay in specimen processing-major source of preanalytical variation in serum electrolytes","volume":"8","author":"Baruah","year":"2014","journal-title":"J. Clin. Diagn. Res.: J. Clin. Diagn. Res."},{"issue":"17","key":"10.1016\/j.conctc.2018.08.008_bib2","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1007\/s00216-015-8565-x","article-title":"Effects of pre-analytical processes on blood samples used in metabolomics studies","volume":"407","author":"Yin","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"issue":"13","key":"10.1016\/j.conctc.2018.08.008_bib3","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1021\/ac051972y","article-title":"Impact of analytical bias in metabonomic studies of human blood serum and plasma","volume":"78","author":"Teahan","year":"2006","journal-title":"Anal. Chem."},{"issue":"4","key":"10.1016\/j.conctc.2018.08.008_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/14789450.3.4.409","article-title":"Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics","volume":"3","author":"Rai","year":"2006","journal-title":"Expet Rev. Proteonomics"},{"issue":"3","key":"10.1016\/j.conctc.2018.08.008_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.mbc.0000164424.90545.6e","article-title":"Effects of pre-analytical variables on the anti-activated factor X chromogenic assay when monitoring unfractionated heparin and low molecular weight heparin anticoagulation","volume":"16","author":"McGlasson","year":"2005","journal-title":"Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis"},{"issue":"5","key":"10.1016\/j.conctc.2018.08.008_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.ftd.0000170879.18139.40","article-title":"Stabilizing drug molecules in biological samples","volume":"27","author":"Chen","year":"2005","journal-title":"Ther. Drug Monit."},{"issue":"3","key":"10.1016\/j.conctc.2018.08.008_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00007691-200106000-00013","article-title":"Stability of therapeutic drugs in serum collected in vacutainer serum separator tubes containing a new gel (SST II)","volume":"23","author":"Bush","year":"2001","journal-title":"Ther. Drug Monit."},{"issue":"9","key":"10.1016\/j.conctc.2018.08.008_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.21037\/atm.2016.04.10","article-title":"Standardizing in vitro diagnostics tasks in clinical trials: a call for action","volume":"4","author":"Lippi","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.conctc.2018.08.008_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2017.01.071","article-title":"Premature discontinuation of pediatric randomized controlled trials: a retrospective cohort study","volume":"184","author":"Schandelmaier","year":"2017","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.conctc.2018.08.008_bib10","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0223","article-title":"Discontinuation and nonpublication of randomized clinical trials conducted in children","volume":"138","author":"Pica","year":"2016","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.conctc.2018.08.008_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2519\/jospt.2014.0110","article-title":"The distinction between randomized clinical trials (RCTs) and preliminary feasibility and pilot studies: what they are and are not","volume":"44","author":"Abbott","year":"2014","journal-title":"J. Orthop. Sports Phys. Ther."},{"issue":"1","key":"10.1016\/j.conctc.2018.08.008_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-10-1","article-title":"A tutorial on pilot studies: the what, why and how","volume":"10","author":"Thabane","year":"2010","journal-title":"BMC Med. Res. Meth."},{"issue":"3","key":"10.1016\/j.conctc.2018.08.008_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150205","article-title":"Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual Framework","volume":"11","author":"Eldridge","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.conctc.2018.08.008_bib14","first-page":"a1655","article-title":"Developing and evaluating complex interventions: the new Medical Research Council guidance","volume":"337","author":"Craig","year":"2008","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.conctc.2018.08.008_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1163\/157180908X333228","article-title":"Ethical considerations for clinical trials on medicinal products conducted with the paediatric population","volume":"15","author":"European Union","year":"2008","journal-title":"Eur. J. Health Law"},{"key":"10.1016\/j.conctc.2018.08.008_bib16","unstructured":"ClinicalTrials.gov, Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril. https:\/\/ClinicalTrials.gov\/show\/NCT02654678."},{"key":"10.1016\/j.conctc.2018.08.008_bib17","unstructured":"ClinicalTrials.gov, Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy https:\/\/ClinicalTrials.gov\/show\/NCT02652728."},{"key":"10.1016\/j.conctc.2018.08.008_bib18","unstructured":"ClinicalTrials.gov, Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease. https:\/\/ClinicalTrials.gov\/show\/NCT02652741."},{"year":"2011","series-title":"Committee for Medicinal Products for Human Use, Guideline on Bioanalytical Method Validation","key":"10.1016\/j.conctc.2018.08.008_bib19"},{"year":"2013","series-title":"Guidance for Industry, Bioanalytical Method Validation Draft Guidance Revision 1","author":"Food and Drug Administration Center for Drug Evaluation and Research","key":"10.1016\/j.conctc.2018.08.008_bib20"},{"key":"10.1016\/j.conctc.2018.08.008_bib21","doi-asserted-by":"crossref","first-page":"796249","DOI":"10.1155\/2015\/796249","article-title":"Sample preparation and extraction in small sample volumes suitable for pediatric clinical studies: challenges, advances, and experiences of a bioanalytical HPLC-MS\/MS method validation using enalapril and enalaprilat","volume":"2015","author":"Burckhardt","year":"2015","journal-title":"Int. J. Anal. Chem."},{"key":"10.1016\/j.conctc.2018.08.008_bib22","first-page":"1","article-title":"Validated low-volume immunoassay for the reliable determination of direct renin especially valuable for pediatric investigations","author":"Schaefer","year":"2017","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.conctc.2018.08.008_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.plabm.2017.07.004","article-title":"Validated low-volume aldosterone immunoassay tailored to GCLP-compliant investigations in small sample volumes","volume":"9","author":"Schaefer","year":"2017","journal-title":"Prac. Lab. Med."},{"issue":"1","key":"10.1016\/j.conctc.2018.08.008_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cct.2014.04.001","article-title":"Pilot and feasibility studies: is there a difference from each other and from a randomised controlled trial?","volume":"38","author":"Whitehead","year":"2014","journal-title":"Contemp. Clin. Trials"},{"issue":"26","key":"10.1016\/j.conctc.2018.08.008_bib25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/01.RES.26.5.591","article-title":"In-vlvo and in-vitro conversion of angiotensin I to angiotensin II in dog blood","volume":"26","author":"Oparil","year":"1970","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.conctc.2018.08.008_bib26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","article-title":"Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement","volume":"55","author":"Campbell","year":"2009","journal-title":"Clin. Chem."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865418300607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865418300607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:22:13Z","timestamp":1763554933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865418300607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":26,"alternative-id":["S2451865418300607"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2018.08.008","relation":{},"ISSN":["2451-8654"],"issn-type":[{"type":"print","value":"2451-8654"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A feasibility study prior to an international multicentre paediatric study to assess pharmacokinetic\/pharmacodynamic sampling and sample preparation procedures, logistics and bioanalysis","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2018.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}